Potential role of mixed ACE and neutral endopeptidase inhibitor in the treatment of heart failure.
Hu
K
K
Ertl
G
G
D000409:Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D006332:Cardiomegaly / Q000188:drug therapy / Q000209:etiology; D006224:Cricetinae; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007668:Kidney / Q000187:drug effects; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D011480:Protease Inhibitors / Q000627:therapeutic use*; D051381:Rats
D000806:Angiotensin-Converting Enzyme Inhibitors; D011480:Protease Inhibitors; C097293:aladotril; D000409:Alanine